linkedin.com/feed/update/ur… The development of antigen-specific regulatory T cells (Tregs) as potential therapeutic candidates for autoimmune diseases is going forward ! #autoimmunedisease #immunotherapy #tcells

ARTiDe is moving forward 🚀🚀🚀 Kickstart your Friday with ARTE and gear up for a great weekend! 😎 Dive into the world of antigen-specific T cells stimulation, enrichment, and analysis with Miltenyi Biotec #FridayFeeling #TCellResearch #type1diabetes #diabetes!

The role of low-dose IL-2 in combination with regulatory T cells as treatment for early-onset #type1diabetes linkedin.com/feed/update/ur…

The effects of interval administration of low-dose recombinant IL-2 in #type1diabetes was examined using high-resolution #singlecell multiomics and #flowcytometry on longitudinally-collected peripheral blood samples of patients. #interleukin2 #treatment nature.com/articles/s4146…

When the antigen-specific TCRβs were looked into in a cohort of patients with new-onset #T1D compared with the controls, shared and frequent TCRβ sequences from those known to recognize insulin or other #βcell proteins and viral antigens were identified. linkedin.com/feed/update/ur…

Autologous polyclonal #Tregs, expanded in vitro, were tested for #type1diabetes #therapy. A phase 2 trial by Bender et al. found that a single dose doesn't alter T1D progression; Treg quality might be crucial. #T1D #immunotherapy #celltherapy

A #hybridinsulinpeptide, HIP9 (human equivalent of murine 2.5HIP), has been isolated. While its relevance in human disease is unclear, it is a potent ligand for the #diabetogenic BDC-2.5 clone. The #study also shows that the analogous CgA HIP is significantly associated with #T1D

📢📢📢 ARTiDe is #hiring! Join the teamb Simon Fillatreau and be part of the journey to discover groundbreaking #therapies for #type1diabetes! Together, we can make a difference! 👉 👉 👉 For more details: nature.com/naturecareers/…

🚨We're hiring! Exciting opportunity for a Postdoc or PhD Fellow to join Simon Fillatreau's Lab at INEM! Work on Microglia in Neuroinflammatory Disease and be part of groundbreaking research. 🔬 🔍Learn more and apply: institut-necker-enfants-malades.fr/index.php/offr…

Join our team at INEM NECKER to work on a new #Immunotherapy for #type1diabetes! Don't hesitate to reach out if you have question! Please #Repost

A great news from our project partner PolTREG ! Some of the #type1diabetes (T1D) patients treated with PolTREG’s cellular #Treg #therapy could go without taking #insulin for up to two years. For more details, click here: poltreg.com/poltreg-treg-c… linkedin.com/posts/poltreg-…

Novel food innovations are crucial in the fight against diabetes. A new low glycaemic index rice variety from the Philippines could help reduce #type2diabetes in regions where #rice is a staple. #HealthInnovation #DiabetesPrevention #SustainableFood theguardian.com/global-develop…